Evaluation of a conjugate of purified antibodies against human AFP-dextran-daunorubicin to human AFP-producing yolk sac tumor cell lines

[1]  R. W. Baldwin,et al.  Antitumor properties of vindesine-monoclonal antibody conjugates , 2004, Cancer Immunology, Immunotherapy.

[2]  N. Hibi,et al.  Suppression of human alpha-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti alpha-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier. , 1985, British Journal of Cancer.

[3]  Y. Takeda,et al.  An anti-alpha-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier. , 1984, Journal of the National Cancer Institute.

[4]  N. Hibi,et al.  The inhibitory effects of horse anti‐rat AFP antiserum on the uptake of 2‐deoxy‐D‐glucose by AFP‐producing rat hepatoma cells , 1984, International journal of cancer.

[5]  K. Taketa,et al.  DISTINCT MOLECULAR SPECIES OF HUMAN α‐FETOPROTEIN DUE TO DIFFERENTIAL AFFINITIES TO LECTINS a , 1983 .

[6]  M. Sawada,et al.  Chemotherapy of human yolk sac tumor heterotransplanted in nude mice. , 1983, Journal of the National Cancer Institute.

[7]  R. W. Baldwin,et al.  Preparation and properties of a drug‐carrier‐antibody conjugate showing selective antibody‐directed cytotoxicity in vitro , 1983, International journal of cancer.

[8]  V. Courtenay,et al.  The response to chemotherapy of a variety of human tumour xenografts. , 1983, British Journal of Cancer.

[9]  R. W. Baldwin,et al.  Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate. , 1983, British Journal of Cancer.

[10]  M. Sela,et al.  Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Sela,et al.  Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[12]  N. Takeichi,et al.  Effect of horse antibody to rat alpha‐fetoprotein upon the growth of AH‐66 in donryu rats , 1980, International journal of cancer.

[13]  T. Terasima,et al.  Immune elimination of host fibroblasts for the cultivation of human tumors transplanted into nude mice. , 1979, Cancer research.

[14]  T. Motoyama.  Evaluation of the regrowth assay method as an in vitro drug sensitivity test and its application to cultured humah gastric cancer cell lines , 1979 .

[15]  H. Bingham.  Chemotherapy of a human malignant melanoma transplanted in the nude mouse , 1976 .

[16]  G. Mizejewski,et al.  Alpha fetoprotein: effect of heterologous antiserum on hepatoma cells in vitro. , 1975, Journal of the National Cancer Institute.

[17]  R. Levy,et al.  The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities. , 1975, Cancer research.

[18]  G. Mizejewski,et al.  Immunotherapeutic suppression in transplantable solid tumours , 1974, Nature.

[19]  H. Watabe,et al.  Effect on anti‐alpha‐fetoprotein serum on some cultured tumor cells , 1974, International journal of cancer.

[20]  H. Hirai,et al.  Purification of human, dog and rabbit -fetoprotein by immunoadsorbents of sepharose coupled with anti-human -fetoprotein. , 1972, Biochimica et biophysica acta.

[21]  J. Rygaard,et al.  Heterotransplantation of a human malignant tumour to "Nude" mice. , 2009, Acta pathologica et microbiologica Scandinavica.